Valeo Financial Advisors, LLC Vaxart, Inc. Transaction History

Valeo Financial Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$5.06 - $10.78 $12,649 - $26,950	-2,500 Closed	0 $0
Q1 2021 Apr 12, 2021	BUY	$5.64 - $23.33 $14,100 - $58,324	2,500 New	2,500 $15,000
Q4 2020 Feb 11, 2021	SELL	$3.5 - $7.98 $1,050 - $2,394	-300 Closed	0 $0
Q3 2020 Oct 28, 2020	BUY	$4.78 - $16.97 $956 - $3,394	200 Added 200.0%	300 $2,000
Q2 2020 Jul 20, 2020	BUY	$1.68 - $8.85 $168 - $885	100 New	100 $1,000

109

37.6M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $75.9M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.